Schmidt, S, Liu, Y, Hu, ZH, Williams, KM, Lazarus, HM, Vij, R, Kharfan-Dabaja, MA, Ortí, G, Wiernik, PH, Weisdorf, D, Kamble, RT, Herzig, R, Wirk, B, Cerny, J, Bacher, U, Chaudhri, NA, Nathan, S, Farhadfar, N, Aljurf, M, Gergis, U, Szer, J, Seo, S, Hsu, JW, Olsson, RF, Maharaj, D, George, B, Hildebrandt, GC, Agrawal, V, Nishihori, T
, Abdel-Azim, H, Alyea, E, Popat, U, Sobecks, R, Scott, BL, Holter Chakrabarty, J & Saber, W 2020, '
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era: Role of DLI in Post-HCT Relapse for CML in the TKI Era',
Biology of Blood and Marrow Transplantation, vol. 26, no. 6, pp. 1137-1143.
https://doi.org/10.1016/j.bbmt.2020.02.006